Emerging drugs for chronic kidney disease. (June 2014)
- Record Type:
- Journal Article
- Title:
- Emerging drugs for chronic kidney disease. (June 2014)
- Main Title:
- Emerging drugs for chronic kidney disease
- Authors:
- Stefoni, Sergio
Cianciolo, Giuseppe
Baraldi, Olga
Iorio, Mario
Angelini, Maria Laura - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Introduction:</italic> </bold> Chronic kidney disease (CKD) is a worldwide health problem. Despite remarkable headway in slowing the progression of kidney diseases, the incidence of end-stage renal disease (ESRD) is increasing in all countries with a severe impact on patients and society. The high incidence of diabetes and hypertension, along with the aging population, may partially explain this growth. Currently, the mainstay of pharmacological treatment for CKD, aiming to slow progression to ESRD are ACE inhibitors and angiotensin II receptor blockers for their hemodynamic/antihypertensive and anti-inflammatory/antifibrotic action. However, novel drugs would be highly desirable to effectively slow the progressive renal function loss.</p> <p> <bold> <italic>Areas covered:</italic> </bold> Through the search engines, PubMed and ClinicalTrial.gov, the scientific literature was reviewed in search of emerging drugs in Phase II or III trials, which appear to be the most promising for CKD treatment.</p> <p> <bold> <italic>Expert opinion:</italic> </bold> The great expectations for new drugs for the management of CKD over the last decade have unfortunately not been met. Encouraging results from preliminary studies with specific agents need to be tempered with caution, given the absence of consistent and adequate data. To date, several agents that showed great promise in animal studies have been<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Introduction:</italic> </bold> Chronic kidney disease (CKD) is a worldwide health problem. Despite remarkable headway in slowing the progression of kidney diseases, the incidence of end-stage renal disease (ESRD) is increasing in all countries with a severe impact on patients and society. The high incidence of diabetes and hypertension, along with the aging population, may partially explain this growth. Currently, the mainstay of pharmacological treatment for CKD, aiming to slow progression to ESRD are ACE inhibitors and angiotensin II receptor blockers for their hemodynamic/antihypertensive and anti-inflammatory/antifibrotic action. However, novel drugs would be highly desirable to effectively slow the progressive renal function loss.</p> <p> <bold> <italic>Areas covered:</italic> </bold> Through the search engines, PubMed and ClinicalTrial.gov, the scientific literature was reviewed in search of emerging drugs in Phase II or III trials, which appear to be the most promising for CKD treatment.</p> <p> <bold> <italic>Expert opinion:</italic> </bold> The great expectations for new drugs for the management of CKD over the last decade have unfortunately not been met. Encouraging results from preliminary studies with specific agents need to be tempered with caution, given the absence of consistent and adequate data. To date, several agents that showed great promise in animal studies have been less effective in humans.</p> </abstract> … (more)
- Is Part Of:
- Expert opinion on emerging drugs. Volume 19:Number 2(2014:Jun.)
- Journal:
- Expert opinion on emerging drugs
- Issue:
- Volume 19:Number 2(2014:Jun.)
- Issue Display:
- Volume 19, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 19
- Issue:
- 2
- Issue Sort Value:
- 2014-0019-0002-0000
- Page Start:
- 183
- Page End:
- 199
- Publication Date:
- 2014-06
- Subjects:
- Drugs -- Research -- Handbooks, manuals, etc
Drugs -- Design -- Periodicals
615.1072 - Journal URLs:
- http://informahealthcare.com/journal/emd ↗
http://informahealthcare.com ↗
http://iris.ashley-pub.com/vl=930529/cl=16/nw=1/rpsv/journal/journal4_home.htm ↗ - DOI:
- 10.1517/14728214.2014.900044 ↗
- Languages:
- English
- ISSNs:
- 1472-8214
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002950
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3507.xml